2026– date –
-
CSPC Pharmaceutical and AstraZeneca Form Joint Venture for AI-Driven GMP Biologics Manufacturing Facility in China
BioPharm International China Overview CSPC Pharmaceutical Group and AstraZeneca have signed a joint venture agreement to construct a next-generation biopharmaceutical manufacturing facility in Shijiazhuang, China. This facility aims to i... -
CellFiber and Tidewave Bio Partner to Evaluate 3D Cell Culture Platform for Scalable Manufacturing of Next-Gen Cell Immunotherapies
BioProcess International Global Overview CellFiber and Tidewave Bio have initiated a joint Proof of Concept (PoC) to evaluate CellFiber's 3D cell culture platform for scalable manufacturing of Tidewave's next-generation cell immunotherap... -
Human Methacryloyl Platelet Lysate Hydrogels Emerge as Robust Xeno-Free Platform for 3D Cell Culture and Tissue Engineering
PMC (National Library of Medicine) USA Overview Novel xeno-free human methacryloyl platelet lysate (hPLMA) hydrogels have been developed, demonstrating robust and reproducible performance in 3D cell culture and tissue engineering applica... -
AI Drives Bioprocess Optimization, Enhancing Titer, Rate, and Yield (TRY) in Pharmaceutical Manufacturing
Corvic AI (Facebook) Global Overview Artificial intelligence (AI) is emerging as a pivotal technology transforming pharmaceutical manufacturing by dramatically boosting efficiency and quality in bioprocess development. Machine learning m... -
Japan Establishes Rigorous Regulatory Framework for Stem Cell and Regenerative Medicine under ASRM
PlacidWay Japan Overview Japan has implemented a stringent regulatory framework for stem cell therapy and regenerative medicine, based on the Act on the Safety of Regenerative Medicine (ASRM). The Ministry of Health, Labour and Welfare (... -
Single-Day Manufactured IL-18-Armed CAR T Cells Demonstrate Durable Anti-Tumor Efficacy and Exhaustion Resistance
Blood - ASH Publications USA Overview Researchers have developed a novel single-day manufacturing process for nonactivated IL-18-armed CAR T cells, exhibiting potent anti-tumor efficacy and enhanced persistence in both in vitro and in vi... -
Aternium Plans Clean Hydrogen Production in Dover, Delaware, Using Zero-Emission Power Without Federal Aid
Delaware Public Media USA Overview Aternium announced plans to produce clean hydrogen in Dover, Delaware, utilizing zero-emission power sources like wind, solar, and nuclear, without relying on federal government support. The company exp... -
SFC Energy Achieves Record H1 2026 Revenue with 47.1% Gross Margin, Driven by Increased Fuel Cell Orders to Ukraine
S&P Global (Market Intelligence) Germany Overview SFC Energy posted record results for H1 2026, with revenue up 12% year-over-year and gross profit margin reaching a significantly improved 47.1%. Growth was driven by the clean energy seg... -
Fuel Cell Energy’s SOFC Achieves Commercial Maturity for AI Data Center On-Site Power Demand
EnkiAI USA Overview 2026 marked a pivotal year as data center developers aggressively adopted on-site fuel cell technology to address surging AI data center power demand and existing grid constraints. Fuel Cell Energy's Solid Oxide Fuel ... -
U.S. DOE Hydrogen and Fuel Cell Technologies Office (HFTO) Announces Funding Opportunity to Advance National Clean Hydrogen Strategy
HigherGov USA Overview The U.S. Department of Energy (DOE)'s Office of Energy Efficiency and Renewable Energy (EERE), on behalf of the Hydrogen and Fuel Cell Technologies Office (HFTO), has announced a Funding Opportunity Announcement (F...
